Sergio Borgia - Concepedia

Author

Sergio Borgia

Also Known As

Alka Chaudhary, Allison Mcgeer, Borgia, Sergio, S Borgia, S M Borgia, S. Borgia, S. M. Borgia, Sergio Borgia, Sergio M Borgia, Sergio M. Borgia

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

William Osler Health System University of Alberta University of Toronto Gilead Sciences (United States)University of Calgary

About

Sergio Borgia is an author at William Osler Health System specializing in medicine, infection control, and emergency medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	364
2	Emergency Medicine	2	2	29
3	Health Sciences	1	1	23
4	Public Health	1	1	12
5	Social Sciences	1	1	19

Sergio Borgia

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes Sergio Borgia, Charlotte Hedskog, Bandita Parhy, The Journal of Infectious Diseases	2018	305
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials Ira M. Jacobson, Eric Lawitz, Edward Gane, Gastroenterology HepatologyViral HepatitisAntiviral Drug DevelopmentRandomized TrialsHepatitis	2017	236
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Jordan J. Feld, Christopher Kandel, Mia J. Biondi, The Lancet Respiratory Medicine	2021	235
Reduced Virulence of Group A Streptococcal Tn <i>916</i> Mutants That Do Not Produce Streptolysin S Stephen Betschel, Sergio Borgia, Neil L. Barg, Infection and Immunity	1998	141
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis Sergio Borgia, Janet Dearden, Eric M. Yoshida, Journal of Hepatology	2019	122
Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification Charlotte Hedskog, Bandita Parhy, Silvia Chang, Open Forum Infectious Diseases	2019	116
Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts Alessandra Mangia, Scott Milligan, Mandana Khalili, Liver International	2020	104
Outbreak of Carbapenem-Resistant Enterobacteriaceae Containing blaNDM-1, Ontario, Canada Sergio Borgia, Olga Lastovetska, Denyse Richardson, Clinical Infectious Diseases	2012	102
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen Sergio Borgia, Jeffrey Fuller, Alicia Sarabia, Medical Mycology Diagnostic MycologyCns BlastomycosisTreatment RegimenPathologyCase Series	2006	64
Emergence of Carbapenemase-Producing<i>Enterobacteriaceae</i>, South-Central Ontario, Canada1 Philipp Köhler, Roberto G. Melano, Samir Patel, Emerging infectious diseases	2018	44

Page 1